Results 101 to 110 of about 347,613 (269)
Factors influencing perceived importance of haemodialysis adherence among end stage kidney failure patients in tertiary care centres in Nepal. [PDF]
Shrestha P +4 more
europepmc +1 more source
Transperitoneal Dialysis [PDF]
openaire +2 more sources
Canagliflozin treatment reshapes the gut microbiota in DKD and elevates levels of melibiose, a metabolite derived from Roseburia intestinalis. Melibiose directly binds to and enhances the enzymatic activity of glyoxalase 1, leading to decreased methylglyoxal accumulation.
Wei Zhang +32 more
wiley +1 more source
Spatial burden and self-managed safety in peritoneal dialysis: a qualitative study based on semi-structured interviews. [PDF]
Kim Y +5 more
europepmc +1 more source
Nanocellulose, derived from microcrystalline cellulose (MCC) through sulfuric acid hydrolysis or mechanical grinding to produce CNC or CNF, was tested in a rat ICP model. Particularly, CNF improved gut microbiota composition, reduced secondary bile acid metabolism, and restored bile acid homeostasis through modulation of the gut–liver axis.
Muhua Yu +18 more
wiley +1 more source
POS-350 REASONS FOR FIRST NEPHROLOGY CONSULTATION IN THE ELDERLY
Y. ELOUAER +11 more
doaj +1 more source
Risk prediction models for malnutrition in dialysis patients in China: a systematic review and meta-analysis. [PDF]
Liu M +6 more
europepmc +1 more source
Ultrasound‐Actuated Gene Editing in Human Kidney Organoids
Peptide‐stabilized nanoemulsions enable spatially controlled, ultrasound‐triggered delivery of gene‐editing proteins deep within human kidney organoid tissues. Focused acoustic pulses drive droplet vaporization, propelling cargo into target renal cells while preserving native tissue microarchitecture. This non‐viral platform improves both the depth and
Michael A. Miller +6 more
wiley +1 more source
An Unusual Cause of Diffuse Bone Pain in a Long-Term Dialysis Patient: A Case Report of β2-Microglobulin Amyloid Arthropathy. [PDF]
Bayala YLT +8 more
europepmc +1 more source
An immunomodulatory hydrogel (iGEL) forms spontaneously upon subcutaneous injection, acting as a tissue‐adhesive depot. It releases anti‐rejection and regenerative agents in response to inflammation, suppressing T‐cell activity, promoting vascular repair, and restoring allograft function without systemic immunosuppression.
Ning Wang +14 more
wiley +1 more source

